Dhanuka Agritech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
DHANUKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.4 pts more than Nifty Microcap 250 and 7.2 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dhanuka Agritech reported audited FY2026 results with revenue from operations at ₹2,01,979 Lacs, slightly lower than FY2025's ₹2,03,515 Lacs. PAT for the year stood at ₹28,723 Lacs versus ₹29,696 Lacs in the prior year, reflecting a decline. The company announced a ₹70 Crore share buyback at ₹1,400 per share for up to 5 lakh shares (1.11% of equity), with promoters intending to participate. A 100% final dividend of ₹2 per share was recommended. The Board also approved an Employee Stock Option Plan (50,000 options) and a Stock Appreciation Rights Plan (1,25,000 SARs), both pending shareholder approval. Plans were approved to set up wholly owned subsidiaries in Brazil and a European country to manage brand transfers from Bayer and register new products internationally. Statutory auditors SS Kothari Mehta issued an unmodified opinion.
Revenue and profit both declined marginally year-on-year, though the company maintains a strong cash position and returns capital via buyback and dividend. The share buyback at a significant premium signals management confidence, while international expansion plans indicate growth ambitions beyond India.